Narcolepsy is a lifelong central hypersomnia characterized by excessive daytime sleepiness, cataplex y, sleep paralysis, hypnagogic hallucinations, and disrupted noc- turnal sleep. Behavioral and psychiatric comorbidities are often associated clinical features. It is divided into t wo subt ypes, narcolepsy t ype -1, and narcolepsy t ype -2, depending on the presence of cataplex y and the cerebrospinal fluid hypocretin-1 l evels. An autoimmune process, along with environmental factors, has been hypothesized to cause the disease. Among children and adolescents, incidence in Europe falls bet ween 0.14 and 0.3 in 100,000, with a reported increase in the incidence af ter the 2009 H1N1 pandemic influence and vaccination. Currently, specific pediatric diagnostic criteria and cut-off instrumental values are lacking. Clinical presentation of the disease may differ between children and adults, and misdiagnoses or diagnostic delays are still an issue. The treatment is based on behavioral and pharmacological therapy, but drugs in children a re prescribed off-l abel. Overall, pathogenic mechanism of narcolepsy and data on drug efficac y in chil dren are still li mited: more research is needed to develop new drugs and to reach approval of current treatments in the pediatric population.

Annamaria Govi, Elena Antelmi, Fabio Pizza, Francesca Ingravallo, Giuseppe Plazzi (2016). Narcolepsy features in young patients. JOURNAL OF PEDIATRIC BIOCHEMISTRY, 06(04), 184-190 [10.1055/s-0037-1602258].

Narcolepsy features in young patients

GOVI, ANNAMARIA;ANTELMI, ELENA;PIZZA, FABIO;INGRAVALLO, FRANCESCA;PLAZZI, GIUSEPPE
2016

Abstract

Narcolepsy is a lifelong central hypersomnia characterized by excessive daytime sleepiness, cataplex y, sleep paralysis, hypnagogic hallucinations, and disrupted noc- turnal sleep. Behavioral and psychiatric comorbidities are often associated clinical features. It is divided into t wo subt ypes, narcolepsy t ype -1, and narcolepsy t ype -2, depending on the presence of cataplex y and the cerebrospinal fluid hypocretin-1 l evels. An autoimmune process, along with environmental factors, has been hypothesized to cause the disease. Among children and adolescents, incidence in Europe falls bet ween 0.14 and 0.3 in 100,000, with a reported increase in the incidence af ter the 2009 H1N1 pandemic influence and vaccination. Currently, specific pediatric diagnostic criteria and cut-off instrumental values are lacking. Clinical presentation of the disease may differ between children and adults, and misdiagnoses or diagnostic delays are still an issue. The treatment is based on behavioral and pharmacological therapy, but drugs in children a re prescribed off-l abel. Overall, pathogenic mechanism of narcolepsy and data on drug efficac y in chil dren are still li mited: more research is needed to develop new drugs and to reach approval of current treatments in the pediatric population.
2016
Annamaria Govi, Elena Antelmi, Fabio Pizza, Francesca Ingravallo, Giuseppe Plazzi (2016). Narcolepsy features in young patients. JOURNAL OF PEDIATRIC BIOCHEMISTRY, 06(04), 184-190 [10.1055/s-0037-1602258].
Annamaria Govi; Elena Antelmi; Fabio Pizza; Francesca Ingravallo; Giuseppe Plazzi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/590749
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact